Skip to content
Visit us at
www.anandandanand.com
Search
PATENTS REWIND : AN ANAND AND ANAND BLOG
Category:
Uncategorized
India’s National IPR policy approved
Concealment of material fact by Ericsson and vacation of injunction on Xiaomi
Gilead granted a Patent for Sofosbuvir
Trastuzumab cannot be sold as a bio similar to Roche’s Trastuzumab
Centre to escalate the process of clearing patent backlogs
DELHI HIGH COURT REFUSES TO STAY ANTI-COMPETITIVE INVESTIGATION AGAINST ERICSSON
IPO RATIONALIZES FER ALLOTMENT AND DISPATCH SYSTEM
PROPOSED GUIDELINES FOR SIMILAR BIOLOGICS
STAY ON THE FIXED PRICE OF BT COTTON BY THE HC
PATENTED TECHNOLOGY COMES AT A FIXED PRICE
Previous Page
Next Page
Subscribe
Subscribed
Patents Rewind - An Anand and Anand Blog
Join 108 other subscribers
Sign me up
Already have a WordPress.com account?
Log in now.
Patents Rewind - An Anand and Anand Blog
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
Patents Rewind - An Anand and Anand Blog 